Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Siemens AG

Start price
Target price
Perf. (%)
€110.00
19.11.20
€116.00
0.42%
19.11.20

Well known brand
High dividend yield expected
buy
Nel ASA

Start price
Target price
Perf. (%)
€2.12
19.11.20
€2.25
6.79%
27.11.20

Future proof or reliable business model
Innovative
Valuable balance sheet
ROE higher than 10% per year
buy
Kazia Therapeutics ADR

Start price
Target price
Perf. (%)
€10.50
19.11.20
-
19.11.21
-28.57%
19.11.21

Risky Investment
buy
Fastly Inc.

Start price
Target price
Perf. (%)
€67.50
19.11.20
€75.00
0.74%
19.11.20

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
Socket Mobile Inc.

Start price
Target price
Perf. (%)
€2.40
19.11.20
-
19.11.21
103.58%
20.11.21

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Probably not worthwhile Investment
Lower EBIT Margin than peer group
Dixie Group Inc.

Start price
Target price
Perf. (%)
€1.61
19.11.20
-
19.11.21
222.98%
20.11.21

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
buy
Vaalco Energy Inc.

Start price
Target price
Perf. (%)
€1.09
19.11.20
-
19.11.21
173.39%
20.11.21

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Probably not worthwhile Investment
buy
Aptevo Therapeutics Inc.

Start price
Target price
Perf. (%)
€42.00
19.11.20
€50.00
19.11.21
-67.07%
07.11.21

Could be very worthwhile Investment >20% year
buy
Knorr-Bremse AG

Start price
Target price
Perf. (%)
€105.04
19.11.20
€108.00
19.11.21
-11.69%
20.11.21

Could be worthwhile Investment >10% per year
buy
Ballard Power Systems Inc.

Start price
Target price
Perf. (%)
€14.55
19.11.20
-
19.11.21
102.82%
01.02.21

Risky Investment
Increased challenges to pay loans and raise capital
Higher risks for its business
Nikola Corp.

Start price
Target price
Perf. (%)
€22.10
18.11.20
-
18.11.21
-23.53%
24.01.21

Innovative
Future proof or reliable business model
Risky Investment
Higher risks for its business
DISH Network Corp. A

Start price
Target price
Perf. (%)
€28.40
18.11.20
-
18.11.21
-11.27%
27.01.21

Higher risks for its business
Very low/no dividend yield expected
Few uniques
buy
Tesla Inc

Start price
Target price
Perf. (%)
€135.75
18.11.20
€145.00
18.11.21
58.13%
20.09.21

Could be worthwhile Investment >10% per year
buy
BYD Co. Ltd

Start price
Target price
Perf. (%)
€19.52
18.11.20
€30.00
18.05.21
-18.98%
18.05.21

Could be very worthwhile Investment >20% year
Very Future proof/growth oriented business model
Top 10 in its market
Known brand
buy
Lenovo Group Ltd

Start price
Target price
Perf. (%)
€0.59
18.11.20
€0.000
5.72%
23.11.20

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
buy
Deutsche Börse AG

Start price
Target price
Perf. (%)
€137.25
18.11.20
€145.00
1.93%
30.11.20

buy
BioNTech SE ADR

Start price
Target price
Perf. (%)
€76.21
18.11.20
€90.00
18.11.21
274.75%
20.08.21

Could be worthwhile Investment >10% per year
Revenue growth > 30% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
Socket Mobile Inc.

Start price
Target price
Perf. (%)
€2.80
18.11.20
€4.00
18.11.21
-25.00%
28.11.20

Could be worthwhile Investment >10% per year
Fair valuation
Bad rating
Few uniques
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€31.40
18.11.20
-
18.11.21
45.06%
19.11.21

EBIT growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
Low dividend yield expected
Nordex SE

Start price
Target price
Perf. (%)
€17.72
18.11.20
-
18.11.21
-14.50%
19.11.21

Revenue growth >5% per year expected
Probably not worthwhile Investment
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
buy
Evoke Pharma Inc.

Start price
Target price
Perf. (%)
€32.66
18.11.20
€60.00
18.11.21
-3.60%
30.11.20

Could be worthwhile Investment >10% per year
buy
Seelos Therapeutics Inc.

Start price
Target price
Perf. (%)
€0.66
18.11.20
€1.00
18.11.21
25.80%
30.11.20

Could be worthwhile Investment >10% per year
buy
Arca Biopharma

Start price
Target price
Perf. (%)
€3.36
18.11.20
€5.00
18.11.21
5.36%
30.11.20

Could be very worthwhile Investment >20% year
buy
SELLAS Life Sciences Group Inc

Start price
Target price
Perf. (%)
€2.39
18.11.20
€4.00
30.50%
30.11.20

Could be worthwhile Investment >10% per year
buy
Phio Pharmaceuticals Corp.

Start price
Target price
Perf. (%)
€22.68
18.11.20
€36.00
2.65%
30.11.20

Could be worthwhile Investment >10% per year